KELLIE PRYOR: Open Payments
NPI 1477807543 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,661 in 111 payments from 18 companies in 2025. Trend: 2023 $1,461 · 2024 $1,457 · 2025 $1,661
Food & beverage: $1,661
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $257 |
| Indivior Inc. | 17 | $187 |
| Neurocrine BioSciences, Inc. | 8 | $157 |
| Lundbeck LLC | 12 | $151 |
| Otsuka America Pharmaceutical, Inc. | 14 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $146 |
| Teva Pharmaceuticals USA, Inc. | 7 | $119 |
| Luye Pharma (USA) Ltd. | 4 | $92 |
| Alkermes, Inc. | 4 | $83 |
| Sage Therapeutics, LLC | 3 | $70 |
Products named: REXULTI, VRAYLAR, SUBLOCADE, INGREZZA, CAPLYTA, AUSTEDO XR, ERZOFRI EXTENDED-RELEASE, ZURZUVAE.
Industry payments across OH — which companies pay providers there.
